E-viri
Recenzirano
-
Rodríguez-Pérez, María Cristo; Orozco-Beltrán, Domingo; Gil-Guillén, Vicente; Domínguez-Coello, Santiago; Almeida-González, Delia; Brito-Díaz, Buenaventura; Marcelino-Rodríguez, Itahisa; Carratalá-Munuera, María Concepción; Gómez-Moreno, Nieves; Navarro-Perez, Jorge; Brotons-Munto, Francisco; Pertusa-Martinez, Salvador; León, Antonio Cabrera de
Diabetes research and clinical practice, 08/2017, Letnik: 130Journal Article
Highlights • DIABSCORE was developed and validated an risk score for screening of type 2 diabetes in a general population cohort. • DIABSCORE showed a high sensitivity to detect cases of type 2 diabetes and a high negative predictive value to rule out the presence of diabetes. • DIABSCORE has showed to be a valid method for opportunistic screening of type 2 diabetes in primary care that is applicable in different populations. • DIABSCORE does not require invasive methods and competes advantageously with blood glucose and HbA1c in terms of patient and professional satisfaction. • DIABSCORE is a cost-effective screening method for type 2 diabetes in primary care compared to the use of blood glucose or HbA1c.
